8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of report (Date of earliest event reported): April 15, 2008

KINETIC CONCEPTS, INC.

(Exact Name of Registrant as Specified in its Charter)

TEXAS	001-09913	74-1891727
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

8023 Vantage Drive San Antonio, Texas	78230
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s telephone number including area code: (210) 524-9000

No change since last report

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01.Regulation FD Disclosure

On April 15, 2008, Kinetic Concepts, Inc. (“KCI”) issued a press release, which is being furnished as Exhibit 99.1 to this Form 8-K.

The information set forth under “Item 7.01 Regulation FD Disclosure,” and in Exhibit 99.1 is intended to be furnished pursuant to Item 7.01. Such information, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. The furnishing of this information pursuant to Item 7.01 shall not be deemed an admission by KCI as to the materiality of such information.

Item 9.01.Financial Statements and Exhibits

(d) Exhibits.

99.1                                  Press Release dated April 15, 2008.

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	KINETIC CONCEPTS, INC.
	By:	/s/ Martin J. Landon
		Name:	Martin J. Landon
		Title:	Sr. Vice President and Chief Financial Officer
Dated: April 15, 2008

3

Exhibit Index

Exhibit No.	Description
99.1	Press Release dated April 15, 2008.

4

EX-99.1

Exhibit 99.1

Kinetic Concepts, Inc. to Offer Convertible Notes

San Antonio, TX — April 15, 2008 —Kinetic Concepts, Inc (NYSE: KCI) today announced that it is planning to offer $600 million aggregate principal amount of convertible senior notes due 2015, subject to market and other customary conditions.  KCI may sell up to an additional $90 million aggregate principal amount of notes upon exercise of an over-allotment option that KCI expects to grant to the initial purchasers in connection with the offering.

Upon conversion, holders will receive cash up to the aggregate principal amount of the notes being converted and shares of KCI common stock in respect of the remainder, if any, of KCI’s conversion obligation in excess of the aggregate principal amount of the notes being converted.

In connection with the offering, KCI intends to enter into convertible note hedge transactions with one or more of the offering’s initial purchasers and/or their affiliates for the purpose of reducing the potential dilution upon future conversion of the notes. KCI also intends to enter into warrant transactions with the same counterparties. The warrant transactions could have a dilutive effect on KCI’s earnings per share to the extent that the price of KCI’s common stock exceeds the strike price of the warrants at exercise.

KCI intends to use a portion of the net proceeds from the offering to pay the cost of the convertible note hedge transactions, taking into account the proceeds to KCI from the warrant transactions, and to use the balance of the net proceeds to fund a portion of the purchase price of the proposed acquisition of LifeCell Corporation, repay certain indebtedness of KCI, provide ongoing working capital and provide for other general corporate purposes of the combined company.

KCI has been advised that, in connection with establishing their initial hedge of the convertible note hedge and warrant transactions described above, KCI’s counterparties or their affiliates expect to enter into various derivative transactions with respect to KCI common stock concurrently with or shortly after the pricing of the notes. These activities could have the effect of increasing, or preventing a decline in, the price of KCI common stock concurrently with or shortly after the pricing of the notes. KCI has been further advised that its counterparties or their affiliates may modify their respective hedge positions by entering into or unwinding various derivative transactions with respect to KCI common stock and/or by purchasing or selling KCI common stock in secondary market transactions during the term of the notes. In particular, such hedge modification transactions are likely to occur during an observation period related to any conversions of the notes, which may have a negative effect on the amount or value of the consideration received in relation to the conversion of those notes. Any of these activities could adversely affect the value of KCI common stock and the value of consideration that holders may receive upon conversion of the notes.

1

The notes and the shares of common stock underlying the notes have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any applicable state securities laws, and will be offered only to qualified institutional buyers pursuant to Rule 144A promulgated under the Securities Act. Unless so registered, the notes may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act and applicable state securities laws.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any state.

Forward Looking Statements

This communication contains forward-looking statements, which may be identified by words such as “believes”, “expects”, “anticipates”, “estimates”, “projects”, “intends”, “should”, “seeks”, “future”, “continue”, or the negative of such terms, or other comparable terminology. Forward-looking statements are subject to risks, uncertainties, assumptions and other factors that are difficult to predict and that could cause actual results to vary materially from those expressed in or indicated by them.  Such forward-looking statements include, but are not limited to, statements about the proposed transaction, KCI’s ability to implement its strategic and business initiatives, including its proposed acquisition of LifeCell, financial expectations and intentions and other statements that are not historical facts.  Additional risks and factors are identified in KCI’s filings with the U.S. Securities Exchange Commission (the “SEC”), including its Report on Form 10-K for the fiscal year ending December 31, 2007, which is available on the SEC’s website at http://www.sec.gov.  KCI undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE: Kinetic Concepts, Inc.

FOR MORE INFORMATION, CONTACT:

Investors:

David Holmes (210) 255-6892

David.holmes@kci1.com

Media:

Kristie Madara (210) 255-6232

Kristie.madara@kci1.com

2